Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects.
Saved in:
| Title: | Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects. |
|---|---|
| Authors: | Qiu H; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Wu T; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China.; Department of Pharmacy, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China., Diao L; Shanghai Fosun Pharmaceutical Development Co., Ltd., Shanghai, China., Yu N; Shanghai Fosun Pharmaceutical Development Co., Ltd., Shanghai, China., Chen H; Fobeni Healthcom Pharmaceutical Jiangsu Co., Ltd., Jiangsu, China., Peng X; Fobeni Healthcom Pharmaceutical Jiangsu Co., Ltd., Jiangsu, China., Jie Huang; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Xie J; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Wu Q; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Yang S; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Yang X; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Zeng L; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Pei Q; Department of Pharmacy, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China., Guo C; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China., Yang G; Central South University Third Xiangya Hospital Center of Clinical Pharmacology Changsha, Changsha, 410013, Hunan, China. ygp9880@126.com.; XiangYa School of Pharmaceutical Sciences, Central South University, Changsha, China. ygp9880@126.com.; Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China. ygp9880@126.com. |
| Source: | Clinical and experimental medicine [Clin Exp Med] 2025 Dec 02; Vol. 26 (1), pp. 96. Date of Electronic Publication: 2025 Dec 02. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1591-9528 |
|---|---|
| DOI: | 10.1007/s10238-025-01951-1 |
